Use of B Vitamins in Pharmacotherapy of Tuberculosis: Retrospective and Marketing Analysis

Author:

Osyntseva AlinaORCID

Abstract

The article provides a comprehensive summary of research findings on the application of group B vitamins in the pharmacotherapy of tuberculosis. This study is grounded in both retrospective and marketing analyses, spanning from 1950 to 2024 and utilizing prominent scientific databases. The findings indicate a significant potential benefit of antioxidant vitamins in the prevention and treatment of tuberculosis, attributed to their antioxidant properties and beneficial effects on the immune system. The marketing analysis highlights the broad availability and popularity of group B vitamins in the Ukrainian market, enhancing the accessibility and economic feasibility of these products. The research offers crucial insights for medical practice and lays a foundation for future studies aimed at advancing tuberculosis prevention and treatment, particularly under conditions of heightened infection risk. Additionally, the article underscores the importance of integrating these vitamins into therapeutic protocols, which could lead to more effective management strategies for tuberculosis and possibly other infectious diseases. By identifying gaps in current treatment approaches and highlighting the economic advantages of group B vitamins, the study also paves the way for public health initiatives to incorporate these findings into broader health policies. This comprehensive approach ensures that both the medical community and policymakers are informed, facilitating a coordinated effort in combating tuberculosis on multiple fronts.

Publisher

Shapovalov Scientific Publishing OU (Publications)

Reference39 articles.

1. Tuberculosis treatment: coverage and outcomes. WHO. 2022. URL: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023/tb-diagnosis---treatment/tb-treatment-and-treatment-coverage

2. Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. Nо.1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.

3. Vovk D., Puhach O., Bachynska L. et al. The Role of the general practitioner-family doctor in the pharmacotherapy of Tuberculosis during the war. SSP Modern Pharmacy and Medicine. 2023. Vo.3. No.3. P.1-7. URL: https://doi.org/10.53933/sspmpm.v3i3.102

4. Patti G., Pellegrino C., Ricciardi A. et al. Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review. Antibiotics (Basel). 2021. Vol. 10. Iss. 11. P. 1354. Doi: 10.3390/antibiotics10111354. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614960/

5. Shapovalova V.O., Mykhailov V.S., Shapovalov V.V. The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice. Fiziolohichnyi zhurnal. 1999. Vol.45. Iss.3. P.114–117. URL: https://pubmed.ncbi.nlm.nih.gov/10439301/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3